Literature DB >> 29128129

Spanish Guidelines on Treatment of Bronchiectasis in Adults.

Miguel Ángel Martínez-García1, Luis Máiz2, Casilda Olveira3, Rosa Maria Girón4, David de la Rosa5, Marina Blanco6, Rafael Cantón7, Montserrat Vendrell8, Eva Polverino9, Javier de Gracia10, Concepción Prados11.   

Abstract

In 2008, the Spanish Society of Pulmonology (SEPAR) published the first guidelines in the world on the diagnosis and treatment of bronchiectasis. Almost 10 years later, considerable scientific advances have been made in both the treatment and the evaluation and diagnosis of this disease, and the original guidelines have been updated to include the latest therapies available for bronchiectasis. These new recommendations have been drafted following a strict methodological process designed to ensure quality of content, and are linked to a large amount of online information that includes a wealth of references. The guidelines are focused on the treatment of bronchiectasis from both a multidisciplinary perspective, including specialty areas and the different healthcare levels involved, and a multidimensional perspective, including a comprehensive overview of the specific aspects of the disease. A series of recommendations have been drawn up, based on an in-depth review of the evidence for treatment of the underlying etiology, the bronchial infection in its different forms of presentation using existing therapies, bronchial inflammation, and airflow obstruction. Nutritional aspects, management of secretions, muscle training, management of complications and comorbidities, infection prophylaxis, patient education, home care, surgery, exacerbations, and patient follow-up are addressed.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Agudizaciones; Antibióticos inhalados; Bronchiectasis; Bronquiectasias; Chronic bronchial infection; Computed tomography; E-FACED; Exacerbations; FACED; Fisioterapia respiratoria; Infección bronquial crónica; Inhaled antibiotics; Macrolides; Macrólidos; Mucolytics; Mucolíticos; Pseudomonas aeruginosa; Respiratory physiotherapy; Tomografía computarizada

Mesh:

Substances:

Year:  2017        PMID: 29128129     DOI: 10.1016/j.arbres.2017.07.016

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  33 in total

1.  Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?

Authors:  Simone K Visser; Peter T P Bye; Greg J Fox; Lucy D Burr; Anne B Chang; Chien-Li Holmes-Liew; Paul King; Peter G Middleton; Graeme P Maguire; Daniel Smith; Rachel M Thomson; Enna Stroil-Salama; Warwick J Britton; Lucy C Morgan
Journal:  Lung       Date:  2019-11-05       Impact factor: 2.584

2.  Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis.

Authors:  Miguel Ángel Martínez-García; Grace Oscullo; Alberto García-Ortega; Maria Gabriella Matera; Paola Rogliani; Mario Cazzola
Journal:  Drugs       Date:  2021-11-26       Impact factor: 9.546

Review 3.  Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review.

Authors:  Miguel Ángel Martínez-García; Mario Cazzola; Grace Oscullo; Alberto García-Ortega; Maria Gabriella Matera; Paola Rogliani
Journal:  Drugs       Date:  2022-10-20       Impact factor: 11.431

Review 4.  Nurse-led versus doctor-led care for bronchiectasis.

Authors:  Kathryn Lawton; Karen Royals; Kristin V Carson-Chahhoud; Fiona Campbell; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2018-06-20

5.  Exercise training for bronchiectasis.

Authors:  Annemarie L Lee; Carla S Gordon; Christian R Osadnik
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

6.  The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.

Authors:  David de la Rosa Carrillo; Rodrigo Athanazio; Rosa Maria Girón Moreno; Luis Máiz Carro; Casilda Olveira; Javier de Gracia; Montserrat Vendrell; Concepción Prados Sánchez; Georgina Gramblicka; Monica Corso Pereira; Fernando Lundgren; Mara Fernandes De Figueiredo; Francisco Arancibia; Samia Rached; Miguel-Angel Martínez-Garcia
Journal:  ERJ Open Res       Date:  2018-03-06

7.  Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study.

Authors:  Vasiliki E Georgakopoulou; Nikolaos Trakas; Christos Damaskos; Nikolaos Garmpis; Evgenia Karakou; Rea Chatzikyriakou; Panagiota Lambrou; Xanthi Tsiafaki
Journal:  Cureus       Date:  2020-08-13

8.  Brazilian consensus on non-cystic fibrosis bronchiectasis.

Authors:  Mônica Corso Pereira; Rodrigo Abensur Athanazio; Paulo de Tarso Roth Dalcin; Mara Rúbia Fernandes de Figueiredo; Mauro Gomes; Clarice Guimarães de Freitas; Fernando Ludgren; Ilma Aparecida Paschoal; Samia Zahi Rached; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

Review 9.  Continuous versus intermittent antibiotics for bronchiectasis.

Authors:  Tim Donovan; Lambert M Felix; James D Chalmers; Stephen J Milan; Alexander G Mathioudakis; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2018-06-03

10.  Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients.

Authors:  Luis Máiz; Rosa M Girón; Eva Prats; Marta G Clemente; Eva Polverino; Silvia Caño; Rosa Cordovilla; Jordi Dorca; Carlos Peñalver; Félix Baranda; Miguel A Martínez-García
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.